InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Fitzpatrick Jennifer. Director active across 1 company, notably Sionna Therapeutics, Inc.. Cumulatively, 5 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €391k. Activity tracked since 4 September 2025. The latest transaction was filed on 6 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Jennifer Fitzpatrick is a declarant linked to Sionna Therapeutics, Inc., where the listed role is Chief Legal Officer. Across 5 filings in total, the 5 sampled filings span from 2025-09-05 to 2026-07-07, with EUR 0 in purchases and EUR 390692 in sales, and the most common transaction nature is option exercise.